论文部分内容阅读
目的探讨疏血通联合尼莫地平治疗脑出血的临床观察。方法将60例患者随机分为两组,对照组30例,治疗组30例,在对照组常规治疗的基础上加用疏血通和尼莫地平静脉滴注,疗程均为14d。两组分别于治疗前及治疗后14d进行CT检查及神经功能缺损评分,比较两组神经功能缺损恢复程度、血肿体积及血肿周围水肿面积。结果与对照组相比,治疗组较对照组血肿体积明显缩小(P<0.05);血肿周围低密度区明显缩小(P<0.05);神经功能缺损评分明显改善(P<0.05)。结论疏血通联合尼莫地平治疗能促进急性脑出血的血肿吸收、血肿周围水肿带的缩小及神经功能缺失改善。
Objective To investigate the clinical observation of Shuxuetong combined with nimodipine in treating cerebral hemorrhage. Methods Sixty patients were randomly divided into two groups: control group (n = 30) and treatment group (n = 30). On the basis of conventional treatment in the control group, Shuxuetong and nimodipine were used intravenously for 14 days. Two groups were scored before treatment and 14d after CT examination and neurological deficit score, recovery of neurological deficit in both groups, hematoma volume and hematoma area around the area. Results Compared with the control group, the hematoma volume of the treatment group was significantly reduced (P <0.05), the density of the surrounding hematoma area was significantly reduced (P <0.05), and the neurological deficit score was significantly improved (P <0.05). Conclusion Shuxuetong combined with nimodipine can promote hematoma absorption in acute intracerebral hemorrhage, reduce edema zone around hematoma and improve neurological deficit.